Genentech (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Genentech" in English language version.

refsWebsite

Global rank English rank

21web.archive.org

1^st place

8fiercebiotech.com

low place

8,828^th place

5gene.com

low place

5nih.gov

4^th place

4doi.org

2^nd place

4harvard.edu

18^th place

17^th place

3nytimes.com

7^th place

3genengnews.com

low place

6,625^th place

2semanticscholar.org

11^th place

8^th place

2worldcat.org

5^th place

1globenewswire.com

2,614^th place

1,549^th place

1fortune.com

433^rd place

284^th place

1sec.gov

572^nd place

436^th place

1greatplacetowork.com

low place

1pbs.org

198^th place

154^th place

1wsj.com

79^th place

65^th place

1hbr.org

2,754^th place

1,686^th place

1forbes.com

54^th place

48^th place

1pharmafile.com

low place

1mercurynews.com

701^st place

439^th place

1sandiegouniontribune.com

1,275^th place

722^nd place

1chcs.org

low place

1bloomberg.com

99^th place

77^th place

bloomberg.com (Global: 99^th place; English: 77^th place)

Genentech Inc Political Action Committee, Bloomberg Business, n.d., archived from the original on August 20, 2015, retrieved July 17, 2015

chcs.org (Global: low place; English: low place)

"History & Funders". Center for Health Care Strategies. 2021. Archived from the original on July 12, 2022. Retrieved July 12, 2022.

doi.org (Global: 2^nd place; English: 2^nd place)

Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Russo, E. (2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Cohen, S.; Chang, A.; Boyer, H.; Helling, R. (1973). "Construction of biologically functional bacterial plasmids in vitro". Proceedings of the National Academy of Sciences of the United States of America. 70 (11): 3240–3244. Bibcode:1973PNAS...70.3240C. doi:10.1073/pnas.70.11.3240. PMC 427208. PMID 4594039.
Itakura, K.; Hirose, T.; Crea, R.; Riggs, A. D.; Heyneker, H. L.; Bolivar, F.; Boyer, H. W. (1977). "Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin". Science. 198 (4321): 1056–1063. Bibcode:1977Sci...198.1056I. doi:10.1126/science.412251. PMID 412251.

fiercebiotech.com (Global: low place; English: 8,828^th place)

Taylor, Nick Paul (May 11, 2020). "Genentech lures Regev from Broad Institute to lead research and early development". FierceBiotech. Retrieved May 25, 2020.
"Genentech strikes $919M deal to buy Tanox". FierceBiotech. November 9, 2006. Archived from the original on April 4, 2017.
Carroll, John (October 3, 2008). "Genentech teams with Glycart on antibody program". FierceBiotech. Archived from the original on April 4, 2017. Retrieved September 18, 2016.
"UCSF enters drug discovery agreement with Genentech". FierceBiotech. February 19, 2010. Archived from the original on April 4, 2017. Retrieved September 18, 2016.
Carroll, John (October 20, 2014). "Genentech pays $150M upfront to partner on NewLink's immuno-oncology drug". FierceBiotech. Archived from the original on June 14, 2016. Retrieved September 18, 2016.
Garde, Damian (October 20, 2015). "Genentech co-signs Nimbus' computer-aided R&D with an oncology pact". FierceBiotech. Archived from the original on July 11, 2016. Retrieved September 18, 2016.
Lawrence, Stacy (June 23, 2016). "Epizyme nabs combo trial deal with Genentech for NHL candidate | FierceBiotech". www.fiercebiotech.com. Archived from the original on September 6, 2016. Retrieved September 18, 2016.
Lawrence, Stacy (September 7, 2016). "Genentech, BioLineRx pair up a checkpoint inhibitor combo". FierceBiotech. Archived from the original on September 11, 2016. Retrieved September 18, 2016.

forbes.com (Global: 54^th place; English: 48^th place)

Herper, Matthew. "Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan". Forbes. Archived from the original on August 16, 2017. Retrieved August 16, 2017.

fortune.com (Global: 433^rd place; English: 284^th place)

"Genentech".

gene.com (Global: low place; English: low place)

"DEPARTURE OF ALEXANDER HARDY & APPOINTMENT OF ASHLEY MAGARGEE AS INTERIM CHIEF EXECUTIVE OFFICER GENENTECH". Genentech. Retrieved November 3, 2023.
"About Us". Gene.com. Archived from the original on August 4, 2014. Retrieved August 22, 2014.
Genentech. "Corporate Overview". Archived from the original on April 18, 2012. Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.
"Living 10 Years in the Future". Genentech. Archived from the original on August 1, 2016.
Genentech Press Release. "University of California and Genentech Settle Patent Infringement Lawsuits". Genentech, Inc. Archived from the original on August 22, 2013. Retrieved November 16, 2015.

genengnews.com (Global: low place; English: 6,625^th place)

Staff writers (July 21, 2008). "Roche Makes $43.7B Bid for Genentech". Genetic Engineering & Biotechnology News. ISSN 1935-472X. Archived from the original on February 3, 2009. Retrieved September 26, 2008.
Staff writers (July 2, 2014). "Genentech acquires Seragon". Genetic Engineering & Biotechnology News. Archived from the original on July 14, 2014. Retrieved July 2, 2014.
"Three Years After Merger, Genentech R&D Outshines That of Roche's | GEN News Highlights". Genetic Engineering News. July 3, 2012. Archived from the original on April 5, 2017. Retrieved September 18, 2016.

globenewswire.com (Global: 2,614^th place; English: 1,549^th place)

"Changes to the Roche Enlarged Corporate Executive Committee" (Press release). Basel, Switzerland: F. Hoffmann-La Roche Ltd. globenewswire. May 11, 2020. Retrieved May 25, 2020.

greatplacetowork.com (Global: low place; English: low place)

"Working at Genentech". Great Place to Work. Retrieved November 18, 2021.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Russo, E. (2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Cohen, S.; Chang, A.; Boyer, H.; Helling, R. (1973). "Construction of biologically functional bacterial plasmids in vitro". Proceedings of the National Academy of Sciences of the United States of America. 70 (11): 3240–3244. Bibcode:1973PNAS...70.3240C. doi:10.1073/pnas.70.11.3240. PMC 427208. PMID 4594039.
Itakura, K.; Hirose, T.; Crea, R.; Riggs, A. D.; Heyneker, H. L.; Bolivar, F.; Boyer, H. W. (1977). "Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin". Science. 198 (4321): 1056–1063. Bibcode:1977Sci...198.1056I. doi:10.1126/science.412251. PMID 412251.

hbr.org (Global: 2,754^th place; English: 1,686^th place)

"The Promise and Challenge of Big Data for Pharma". Archived from the original on April 5, 2017. Retrieved April 5, 2017.

mercurynews.com (Global: 701^st place; English: 439^th place)

Varian, Ethan (March 25, 2023). "Genentech lays off 265 workers in South San Francisco, closes manufacturing plant". The Mercury News.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Russo, E. (2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Cohen, S.; Chang, A.; Boyer, H.; Helling, R. (1973). "Construction of biologically functional bacterial plasmids in vitro". Proceedings of the National Academy of Sciences of the United States of America. 70 (11): 3240–3244. Bibcode:1973PNAS...70.3240C. doi:10.1073/pnas.70.11.3240. PMC 427208. PMID 4594039.
Itakura, K.; Hirose, T.; Crea, R.; Riggs, A. D.; Heyneker, H. L.; Bolivar, F.; Boyer, H. W. (1977). "Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin". Science. 198 (4321): 1056–1063. Bibcode:1977Sci...198.1056I. doi:10.1126/science.412251. PMID 412251.

ncbi.nlm.nih.gov

Cohen, S.; Chang, A.; Boyer, H.; Helling, R. (1973). "Construction of biologically functional bacterial plasmids in vitro". Proceedings of the National Academy of Sciences of the United States of America. 70 (11): 3240–3244. Bibcode:1973PNAS...70.3240C. doi:10.1073/pnas.70.11.3240. PMC 427208. PMID 4594039.

nytimes.com (Global: 7^th place; English: 7^th place)

Fisher, Lawrence M. (October 1, 2000). "Genentech: Survivor Strutting Its Stuff". The New York Times. Archived from the original on April 4, 2017. Retrieved February 19, 2017.
Pollack, Andrew (March 12, 2009). "Roche Agrees to Buy Genentech for $46.8 Billion". The New York Times. ISSN 0362-4331. Retrieved April 3, 2020.
Pear, Robert. "In House, Many Spoke with One Voice: Lobbyists" Archived August 31, 2019, at the Wayback Machine, New York Times, November 15, 2009.

pbs.org (Global: 198^th place; English: 154^th place)

"In January 1976, 28-year-old venture capitalist Robert Swanson entered the picture. A successful cold-call to Boyer's lab led to a couple of beers—and an agreement to start a pharmaceutical company. Investing $500 each, they capitalized a new business, Genentech, to seek practical uses for Boyer and Cohen's engineered proteins. Swanson raised money for staff and labs...""Who made America? Herbert Boyer". PBS. Archived from the original on June 20, 2012. Retrieved August 28, 2017.

pharmafile.com (Global: low place; English: low place)

"Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn - Pharmafile". pharmafile.com. March 20, 2024. Retrieved March 20, 2024.

sandiegouniontribune.com (Global: 1,275^th place; English: 722^nd place)

Rocha, Natalie (February 21, 2023). "Genentech expands in Oceanside with $450M biotech manufacturing facility and 150 jobs". The San Diego Union-Tribune.

sec.gov (Global: 572^nd place; English: 436^th place)

"FORM 10-K".

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
Russo, E. (2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.

web.archive.org (Global: 1^st place; English: 1^st place)

"About Us". Gene.com. Archived from the original on August 4, 2014. Retrieved August 22, 2014.
Genentech. "Corporate Overview". Archived from the original on April 18, 2012. Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.
"In January 1976, 28-year-old venture capitalist Robert Swanson entered the picture. A successful cold-call to Boyer's lab led to a couple of beers—and an agreement to start a pharmaceutical company. Investing $500 each, they capitalized a new business, Genentech, to seek practical uses for Boyer and Cohen's engineered proteins. Swanson raised money for staff and labs...""Who made America? Herbert Boyer". PBS. Archived from the original on June 20, 2012. Retrieved August 28, 2017.
Fisher, Lawrence M. (October 1, 2000). "Genentech: Survivor Strutting Its Stuff". The New York Times. Archived from the original on April 4, 2017. Retrieved February 19, 2017.
"Genentech strikes $919M deal to buy Tanox". FierceBiotech. November 9, 2006. Archived from the original on April 4, 2017.
Staff writers (July 21, 2008). "Roche Makes $43.7B Bid for Genentech". Genetic Engineering & Biotechnology News. ISSN 1935-472X. Archived from the original on February 3, 2009. Retrieved September 26, 2008.
Staff writers (July 2, 2014). "Genentech acquires Seragon". Genetic Engineering & Biotechnology News. Archived from the original on July 14, 2014. Retrieved July 2, 2014.
"Three Years After Merger, Genentech R&D Outshines That of Roche's | GEN News Highlights". Genetic Engineering News. July 3, 2012. Archived from the original on April 5, 2017. Retrieved September 18, 2016.
"Living 10 Years in the Future". Genentech. Archived from the original on August 1, 2016.
Carroll, John (October 3, 2008). "Genentech teams with Glycart on antibody program". FierceBiotech. Archived from the original on April 4, 2017. Retrieved September 18, 2016.
"UCSF enters drug discovery agreement with Genentech". FierceBiotech. February 19, 2010. Archived from the original on April 4, 2017. Retrieved September 18, 2016.
Carroll, John (October 20, 2014). "Genentech pays $150M upfront to partner on NewLink's immuno-oncology drug". FierceBiotech. Archived from the original on June 14, 2016. Retrieved September 18, 2016.
"The Promise and Challenge of Big Data for Pharma". Archived from the original on April 5, 2017. Retrieved April 5, 2017.
Herper, Matthew. "Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan". Forbes. Archived from the original on August 16, 2017. Retrieved August 16, 2017.
Garde, Damian (October 20, 2015). "Genentech co-signs Nimbus' computer-aided R&D with an oncology pact". FierceBiotech. Archived from the original on July 11, 2016. Retrieved September 18, 2016.
Lawrence, Stacy (June 23, 2016). "Epizyme nabs combo trial deal with Genentech for NHL candidate | FierceBiotech". www.fiercebiotech.com. Archived from the original on September 6, 2016. Retrieved September 18, 2016.
Lawrence, Stacy (September 7, 2016). "Genentech, BioLineRx pair up a checkpoint inhibitor combo". FierceBiotech. Archived from the original on September 11, 2016. Retrieved September 18, 2016.
"History & Funders". Center for Health Care Strategies. 2021. Archived from the original on July 12, 2022. Retrieved July 12, 2022.
Genentech Inc Political Action Committee, Bloomberg Business, n.d., archived from the original on August 20, 2015, retrieved July 17, 2015
Genentech Press Release. "University of California and Genentech Settle Patent Infringement Lawsuits". Genentech, Inc. Archived from the original on August 22, 2013. Retrieved November 16, 2015.
Pear, Robert. "In House, Many Spoke with One Voice: Lobbyists" Archived August 31, 2019, at the Wayback Machine, New York Times, November 15, 2009.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Staff writers (July 21, 2008). "Roche Makes $43.7B Bid for Genentech". Genetic Engineering & Biotechnology News. ISSN 1935-472X. Archived from the original on February 3, 2009. Retrieved September 26, 2008.
Pollack, Andrew (March 12, 2009). "Roche Agrees to Buy Genentech for $46.8 Billion". The New York Times. ISSN 0362-4331. Retrieved April 3, 2020.

wsj.com (Global: 79^th place; English: 65^th place)

Morse, Andrew (May 10, 2006). "Chugai Shares Post Healthy Gain On Prospects for Cancer Drug". The Wall Street Journal. Retrieved September 26, 2008.

Genentech (English Wikipedia)

bloomberg.com (Global: 99th place; English: 77th place)

chcs.org (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

fiercebiotech.com (Global: low place; English: 8,828th place)

forbes.com (Global: 54th place; English: 48th place)

fortune.com (Global: 433rd place; English: 284th place)

gene.com (Global: low place; English: low place)

genengnews.com (Global: low place; English: 6,625th place)

globenewswire.com (Global: 2,614th place; English: 1,549th place)

greatplacetowork.com (Global: low place; English: low place)

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

hbr.org (Global: 2,754th place; English: 1,686th place)

mercurynews.com (Global: 701st place; English: 439th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nytimes.com (Global: 7th place; English: 7th place)

pbs.org (Global: 198th place; English: 154th place)

pharmafile.com (Global: low place; English: low place)

sandiegouniontribune.com (Global: 1,275th place; English: 722nd place)

sec.gov (Global: 572nd place; English: 436th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

wsj.com (Global: 79th place; English: 65th place)

bloomberg.com (Global: 99^th place; English: 77^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

forbes.com (Global: 54^th place; English: 48^th place)

fortune.com (Global: 433^rd place; English: 284^th place)

genengnews.com (Global: low place; English: 6,625^th place)

globenewswire.com (Global: 2,614^th place; English: 1,549^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

hbr.org (Global: 2,754^th place; English: 1,686^th place)

mercurynews.com (Global: 701^st place; English: 439^th place)

nih.gov (Global: 4^th place; English: 4^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

pbs.org (Global: 198^th place; English: 154^th place)

sandiegouniontribune.com (Global: 1,275^th place; English: 722^nd place)

sec.gov (Global: 572^nd place; English: 436^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)

wsj.com (Global: 79^th place; English: 65^th place)